Anton V. Lopukhov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Anton V. Lopukhov has a total of 142 co-authors. Here are the top co-authors by number of shared publications:
- Natalia L. Klyachko
Department of Chemistry, Lomonosov Moscow State University, Moscow 119991, Russia
11 shared publications - Alexander G. Majouga
Faculty of Chemical and Pharmaceutical Technologies and Biomedical Products, Mendeleev University of Chemical Technology of Russia, 125047 Moscow, Russia
4 shared publications Alexander S. Erofeev
Lomonosov Moscow State University, Moscow 119991, Russian Federation
3 shared publicationsElena K. Beloglazkina
Lomonosov Moscow State University, Moscow 119991, Russian Federation
3 shared publications- Elena Kimovna Beloglazkina
Lomonosov Moscow State University, Moscow, Russia, Russia
3 shared publications Elena V. Lopatukhina
Lomonosov Moscow State University, Moscow 119991, Russian Federation
3 shared publications
Latest Publications
- Open Access
Influence of Polymer Backbone Architecture and Amino Group Density on the Cytotoxicity and Transfection Performance of Cationic Block Copolymer Polyplexes
The development of efficient and biocompatible polymeric vectors remains a cornerstone of successful gene therapy. In this study, we developed a versatile polymeric platform for nucleic acid delivery by synthesizing a series of cationic block copolymers based on polyaspartamide or polyglutamide backbones and polyethylene glycol (PEG) segments. Block copolymer precursors were synthesized via ring-opening polymerization. The degrees of polymerization were confirmed via 1H NMR spectroscopy, followed by functionalization with diethylenetriamine, spermine, or spermidine. Cytotoxicity was evaluated using the WST-1 assay in HEK293 and SH-SY5Y cells. Cytotoxicity profiling identified N3-PEG114-b-pAsp(DET)62 as the least cytotoxic polymer among the tested derivatives in both cell lines. The polyplexes enhanced reporter gene expression compared with naked plasmid DNA, and an N/P ratio of 15 was selected for subsequent comparative experiments. In SH-SY5Y neuroblastoma cells, the material obtained following the dopamine-modification procedure exhibited a 1.78-fold increase in reporter fluorescence and a 1.75-fold increase in the percentage of GFP-positive cells compared with the corresponding unmodified formulation. These findings establish the engineered block copolymers as highly adaptable, low-toxicity, and efficient candidates for targeted nucleic acid delivery and support the potential of dopamine functionalization for enhancing delivery to dopamine-receptor-expressing cells.
Open AccessInfluence of Polymer Backbone Architecture and Amino Group Density on the Cytotoxicity and Transfection Performance of Cationic Block Copolymer Polyplexes
The development of efficient and biocompatible polymeric vectors remains a cornerstone of successful gene therapy. In this study, we developed a versatile polymeric platform for nucleic acid delivery by synthesizing a series of cationic block copolymers based on polyaspartamide or polyglutamide backbones and polyethylene glycol (PEG) segments. Block copolymer precursors were synthesized via ring-opening polymerization. The degrees of polymerization were confirmed via 1H NMR spectroscopy, followed by functionalization with diethylenetriamine, spermine, or spermidine. Cytotoxicity was evaluated using the WST-1 assay in HEK293 and SH-SY5Y cells. Cytotoxicity profiling identified N3-PEG114-b-pAsp(DET)62 as the least cytotoxic polymer among the tested derivatives in both cell lines. The polyplexes enhanced reporter gene expression compared with naked plasmid DNA, and an N/P ratio of 15 was selected for subsequent comparative experiments. In SH-SY5Y neuroblastoma cells, the material obtained following the dopamine-modification procedure exhibited a 1.78-fold increase in reporter fluorescence and a 1.75-fold increase in the percentage of GFP-positive cells compared with the corresponding unmodified formulation. These findings establish the engineered block copolymers as highly adaptable, low-toxicity, and efficient candidates for targeted nucleic acid delivery and support the potential of dopamine functionalization for enhancing delivery to dopamine-receptor-expressing cells.
- 4 September 2026
- Published by Pleiades Publishing Ltd in Russian Journal of Bioorganic Chemistry
- Vol. 52 (5) , 130
Modern Challenges of Antimicrobial Resistance and Innovative Approaches to the Treatment of Bacterial Infections
The global expansion of antimicrobial resistance poses a formidable threat to public health. Ongoing bacterial evolution and phenotypic adaptation progressively render conventional antimicrobial strategies resource-intensive and less efficacious, while concurrently exacerbating treatment-associated adverse effects. Consequently, there is an imperative demand to refine existing therapeutic modalities, implement synergistic combinations, and pioneer fundamentally novel strategies to combat infections precipitated by multidrug-resistant pathogens. This review delineates the primary molecular mechanisms governing bacterial resistance and underscores the clinical impact of key infectious diseases. The cornerstone of this work lies in a comprehensive analysis of both canonical and innovative paradigms in antibacterial therapy. By synthesizing state-of-the-art scientific data, this paper provides a definitive perspective on the most promising frontiers in infectious disease management.
- 4 September 2026
- Published by Pleiades Publishing Ltd in Russian Journal of Bioorganic Chemistry
- Vol. 52 (5) , 130
Modern Challenges of Antimicrobial Resistance and Innovative Approaches to the Treatment of Bacterial Infections
The global expansion of antimicrobial resistance poses a formidable threat to public health. Ongoing bacterial evolution and phenotypic adaptation progressively render conventional antimicrobial strategies resource-intensive and less efficacious, while concurrently exacerbating treatment-associated adverse effects. Consequently, there is an imperative demand to refine existing therapeutic modalities, implement synergistic combinations, and pioneer fundamentally novel strategies to combat infections precipitated by multidrug-resistant pathogens. This review delineates the primary molecular mechanisms governing bacterial resistance and underscores the clinical impact of key infectious diseases. The cornerstone of this work lies in a comprehensive analysis of both canonical and innovative paradigms in antibacterial therapy. By synthesizing state-of-the-art scientific data, this paper provides a definitive perspective on the most promising frontiers in infectious disease management.
- 7 April 2026
- Published by VSMU N.N. Burdenko in Journal of Anatomy and Histopathology
- Vol. 15 (1)
Properties of Tissue-Nonspecific Alkaline Phosphatase from Mammalian Testes
The enzyme systems of living organisms catalyse biochemical reactions and are an important component of the functioning of organs and systems. Alkaline phosphatase is localised on the plasma membranes of cells and catalyses the hydrolysis of the phosphoester bond. This enzyme is found in liver, bone, kidney, intestine, placenta and many other organs and tissues. Levels of alkaline phosphatase activity can be altered in various diseases. Despite the universality of the mechanism of action, the function of alkaline phosphatase is poorly understood. Characteristics of alkaline phosphatase isoenzymes, both tissue-specific and tissue-specific: intestinal, germinal, placental. The analysis of literature data on the study of tissue-specific alkaline phosphatase function in bone calcification, in the accumulation of triglycerides by adipose tissue cells, in embryonic development and in spermatogenesis is performed. This review presents an analysis of data on the localisation of alkaline phosphatase in mammalian testes. Alkaline phosphatase was detected in the peritubular cells of the seminiferous tubules and in spermatogonia. Weak reactivity to alkaline phosphatase was observed in Sertoli cells. The enzyme is species-specific: it has been detected in the testes of rats, mice, dogs, guinea pigs, and human testes. Hamsters, rabbits, and bats do not express alkaline phosphatase. The molecular structure of alkaline phosphatase and its properties in relation to standard inhibitors have been characterised. However, the effect of the enzyme on the differentiation of primary germ cells and on the maturation of spermatogenesis cells in mammalian testes has not been studied. Further studies are needed to determine the role of alkaline phosphatase in the physiology of cells and tissues of the reproductive system, including germ cell meiosis.
- 7 April 2026
- Published by VSMU N.N. Burdenko in Journal of Anatomy and Histopathology
- Vol. 15 (1)
Properties of Tissue-Nonspecific Alkaline Phosphatase from Mammalian Testes
The enzyme systems of living organisms catalyse biochemical reactions and are an important component of the functioning of organs and systems. Alkaline phosphatase is localised on the plasma membranes of cells and catalyses the hydrolysis of the phosphoester bond. This enzyme is found in liver, bone, kidney, intestine, placenta and many other organs and tissues. Levels of alkaline phosphatase activity can be altered in various diseases. Despite the universality of the mechanism of action, the function of alkaline phosphatase is poorly understood. Characteristics of alkaline phosphatase isoenzymes, both tissue-specific and tissue-specific: intestinal, germinal, placental. The analysis of literature data on the study of tissue-specific alkaline phosphatase function in bone calcification, in the accumulation of triglycerides by adipose tissue cells, in embryonic development and in spermatogenesis is performed. This review presents an analysis of data on the localisation of alkaline phosphatase in mammalian testes. Alkaline phosphatase was detected in the peritubular cells of the seminiferous tubules and in spermatogonia. Weak reactivity to alkaline phosphatase was observed in Sertoli cells. The enzyme is species-specific: it has been detected in the testes of rats, mice, dogs, guinea pigs, and human testes. Hamsters, rabbits, and bats do not express alkaline phosphatase. The molecular structure of alkaline phosphatase and its properties in relation to standard inhibitors have been characterised. However, the effect of the enzyme on the differentiation of primary germ cells and on the maturation of spermatogenesis cells in mammalian testes has not been studied. Further studies are needed to determine the role of alkaline phosphatase in the physiology of cells and tissues of the reproductive system, including germ cell meiosis.
- 21 December 2024
- Published by ECO-Vector LLC in Russian Journal of Oncology
- Vol. 29 (3) , 211-223
Evaluation of biodistribution of Riboplatin, a Pt(IV) double prodrug based on cisplatin, using fluorescent visualization
BACKGROUND: Developing new platinum-based antitumor agents with improved efficacy and reduced toxicity remains a critical challenge. One promising approach is the synthesis of Pt(IV) prodrugs, such as precursor complexes of cisplatin and its analogs, which release active Pt(II) directly into the intracellular environment of malignant cells. To determine the optimal administration route for these new platinum-based drugs in vivo, it is essential to study their acute toxicity and biodistribution in vital organs. AIM: To evaluate the tolerability, acute toxicity, biodistribution, and accumulation in breast tumors of Riboplatin and its liposomal formulation. MATERIALS AND METHODS: The study was conducted at Moscow Pedagogical State University in female BALB/c mice (healthy or bearing transplanted breast adenocarcinoma EMT-6) and in immunodeficient BALB/c nude mice (bearing human breast adenocarcinoma SK-BR-3). The fluorescence imaging and inductively coupled plasma mass spectrometry were used. RESULTS: A single dose (up to 48 mg/kg) of either water solution or liposomal formulation of Riboplatin did not cause any decrease of body weight in mice. The animals tolerated the dose 48 mg/kg of the drug, whereas the body weight decreased by less than 5% within 3 days. The distribution of Riboplatin and of its liposomal formulation over the body organs was assessed in BALB/c nude mice using fluorescence imaging and inductively coupled plasma mass spectrometry. Both forms provided Riboplatin delivering to EMT-6 tumor. Riboplatin in the form of water solution was predominantly excreted through liver and kidney, while the liposomal formulation lewd to drug accumulation in the spleen. CONCLUSION: Riboplatin is a Pt(IV) prodrug with good tolerability, reduced toxicity compared with cisplatin, with effective accumulation in malignant breast tumors. The opportunity of assessing Riboplatin biodistribution in vivo in EMT-6 and SK-BR-3 tumor lines using fluorescence imaging has been demonstrated. Significant Riboplatin accumulation in EMT-6 tumors suggests the possibility of riboflavin-specific uptake.
- 21 December 2024
- Published by ECO-Vector LLC in Russian Journal of Oncology
- Vol. 29 (3) , 211-223
Evaluation of biodistribution of Riboplatin, a Pt(IV) double prodrug based on cisplatin, using fluorescent visualization
BACKGROUND: Developing new platinum-based antitumor agents with improved efficacy and reduced toxicity remains a critical challenge. One promising approach is the synthesis of Pt(IV) prodrugs, such as precursor complexes of cisplatin and its analogs, which release active Pt(II) directly into the intracellular environment of malignant cells. To determine the optimal administration route for these new platinum-based drugs in vivo, it is essential to study their acute toxicity and biodistribution in vital organs. AIM: To evaluate the tolerability, acute toxicity, biodistribution, and accumulation in breast tumors of Riboplatin and its liposomal formulation. MATERIALS AND METHODS: The study was conducted at Moscow Pedagogical State University in female BALB/c mice (healthy or bearing transplanted breast adenocarcinoma EMT-6) and in immunodeficient BALB/c nude mice (bearing human breast adenocarcinoma SK-BR-3). The fluorescence imaging and inductively coupled plasma mass spectrometry were used. RESULTS: A single dose (up to 48 mg/kg) of either water solution or liposomal formulation of Riboplatin did not cause any decrease of body weight in mice. The animals tolerated the dose 48 mg/kg of the drug, whereas the body weight decreased by less than 5% within 3 days. The distribution of Riboplatin and of its liposomal formulation over the body organs was assessed in BALB/c nude mice using fluorescence imaging and inductively coupled plasma mass spectrometry. Both forms provided Riboplatin delivering to EMT-6 tumor. Riboplatin in the form of water solution was predominantly excreted through liver and kidney, while the liposomal formulation lewd to drug accumulation in the spleen. CONCLUSION: Riboplatin is a Pt(IV) prodrug with good tolerability, reduced toxicity compared with cisplatin, with effective accumulation in malignant breast tumors. The opportunity of assessing Riboplatin biodistribution in vivo in EMT-6 and SK-BR-3 tumor lines using fluorescence imaging has been demonstrated. Significant Riboplatin accumulation in EMT-6 tumors suggests the possibility of riboflavin-specific uptake.
- 1 December 2024
- Published by Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii in Russian Chemical Reviews
- Vol. 93 (12) , RCR5144
Biocatalysis: modern challenges and applications
The review analyzes recent advances, challenges, and practical applications in the field of enzymes within the framework of chemical enzymology and enzyme engineering. The achievements in the fundamental understanding of molecular mechanisms of the catalytic cycle of enzymatic reactions made using quantum mechanics/molecular mechanics methods with supercomputer technologies and bioinformatic approaches are considered. The design of protein biocatalysts with new properties is a fundamentally significant methodology of the bioengineering approach to solving practical problems, which is demonstrated by a number of examples. The increasing role of biocatalysis in medicine and biomedical research is illustrated by addressing the problems of antibiotic synthesis and overcoming antibiotic resistance of bacteria, mechanisms of neurodegenerative diseases and development of drugs to treat Alzheimer's disease, biocatalytic processes of DNA repair and the role of mechanisms of functioning of heme peroxidases in the human body. The use of enzymes to degrade endogenous and exogenous toxicants has been greatly developed in recent decades. The advances and problems of using enzymes in therapy and drug delivery are analyzed. The fundamental role of enzymes in modern analysis and diagnosis is noted. The review considers a new trend in the development of bioanalytical methods using aptamers, multi-analysis systems on biochips, surface-enhanced Raman scattering systems, and bioelectroanalysis. The bibliography includes 460 references.
- 1 December 2024
- Published by Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii in Russian Chemical Reviews
- Vol. 93 (12) , RCR5144
Biocatalysis: modern challenges and applications
The review analyzes recent advances, challenges, and practical applications in the field of enzymes within the framework of chemical enzymology and enzyme engineering. The achievements in the fundamental understanding of molecular mechanisms of the catalytic cycle of enzymatic reactions made using quantum mechanics/molecular mechanics methods with supercomputer technologies and bioinformatic approaches are considered. The design of protein biocatalysts with new properties is a fundamentally significant methodology of the bioengineering approach to solving practical problems, which is demonstrated by a number of examples. The increasing role of biocatalysis in medicine and biomedical research is illustrated by addressing the problems of antibiotic synthesis and overcoming antibiotic resistance of bacteria, mechanisms of neurodegenerative diseases and development of drugs to treat Alzheimer's disease, biocatalytic processes of DNA repair and the role of mechanisms of functioning of heme peroxidases in the human body. The use of enzymes to degrade endogenous and exogenous toxicants has been greatly developed in recent decades. The advances and problems of using enzymes in therapy and drug delivery are analyzed. The fundamental role of enzymes in modern analysis and diagnosis is noted. The review considers a new trend in the development of bioanalytical methods using aptamers, multi-analysis systems on biochips, surface-enhanced Raman scattering systems, and bioelectroanalysis. The bibliography includes 460 references.
- Open Access
- 22 December 2023
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 9 (1) , 858-865
Novel His-tag Variants for Insertion Inside Polypeptide Chain
His-tags are protein affinity tags ubiquitously used due to their convenience and effectiveness. However, in some individual cases, the attachment of His-tags to a protein's N- or C-termini resulted in impairment of the protein's structure or function, which led to attempts to include His-tags inside of polypeptide chains. In this work, we describe newly designed internal His-tags, where two triplets of histidine residues are separated by glycine residues to avoid steric hindrances and consequently minimize their impact on the protein structure. The applicability of these His-tags was tested with eGFP, a multifaceted reference protein, and GrAD207, a modified apical domain of GroEL chaperone, designed to stabilize in soluble form initially insoluble proteins. Both proteins are used as fusion partners for different purposes, and providing them with His-tags introduced into their polypeptide chains should conveniently broaden their functionality without involving the termini. We conclude that the insertable tags may be adjusted for the purification of proteins belonging to different structural classes.
- 22 December 2023
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 9 (1) , 858-865
Open AccessNovel His-tag Variants for Insertion Inside Polypeptide Chain
His-tags are protein affinity tags ubiquitously used due to their convenience and effectiveness. However, in some individual cases, the attachment of His-tags to a protein's N- or C-termini resulted in impairment of the protein's structure or function, which led to attempts to include His-tags inside of polypeptide chains. In this work, we describe newly designed internal His-tags, where two triplets of histidine residues are separated by glycine residues to avoid steric hindrances and consequently minimize their impact on the protein structure. The applicability of these His-tags was tested with eGFP, a multifaceted reference protein, and GrAD207, a modified apical domain of GroEL chaperone, designed to stabilize in soluble form initially insoluble proteins. Both proteins are used as fusion partners for different purposes, and providing them with His-tags introduced into their polypeptide chains should conveniently broaden their functionality without involving the termini. We conclude that the insertable tags may be adjusted for the purification of proteins belonging to different structural classes.
- 1 February 2023
- Published by Pleiades Publishing Ltd in Russian Journal of Organic Chemistry
- Vol. 59 (2) , 270-279
Synthesis and Inhibitory Activity of Atorvastatin Conjugate with a Branched Asialoglycoprotein Receptor Ligand Containing Three N-Acetyl-d-galactosamine Residues
A novel atorvastatin conjugate was synthesized by a multistep procedure, using a branched N-acetylgalactosamine ligand for asialoglycoprotein receptor targeting. The molar solubility of the synthesized conjugate was 6.1 ± 0.9 mM, which is almost 60 times higher compared to unmodified atorvastatin. The hydrolysis products of the conjugate demonstrated effective inhibition of 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase.
- 1 February 2023
- Published by Pleiades Publishing Ltd in Russian Journal of Organic Chemistry
- Vol. 59 (2) , 270-279
Synthesis and Inhibitory Activity of Atorvastatin Conjugate with a Branched Asialoglycoprotein Receptor Ligand Containing Three N-Acetyl-d-galactosamine Residues
A novel atorvastatin conjugate was synthesized by a multistep procedure, using a branched N-acetylgalactosamine ligand for asialoglycoprotein receptor targeting. The molar solubility of the synthesized conjugate was 6.1 ± 0.9 mM, which is almost 60 times higher compared to unmodified atorvastatin. The hydrolysis products of the conjugate demonstrated effective inhibition of 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase.
- 1 February 2023
- Published by Pleiades Publishing Ltd in Russian Journal of Organic Chemistry
- Vol. 59 (2) , 224-236
Synthesis and Affinity of Novel Triantennary Ligands for the Asialoglycoprotein Receptor
Novel triantennary N-acetylgalactosamine derivatives of tris(hydroxymethyl)aminomethane were synthesized and used to form complexes with the asialoglicoprotein receptor expressed on the hepatocellular surface. The equilibrium dissociation constants (KD) of the complexes of the asialoglicoprotein receptor with the synthesized compounds were measured by surface plasmon resonance spectroscopy. The KD values were in the subnanomolar range, being 6 orders of magnitude lower than the respective values for the complex of the receptor with the natural N-acetylgalactosamine ligand. The resulting data suggest that the synthesized ligands are promising agents for targeted delivery of various therapeutic agents in hepatocytes.
- 1 February 2023
- Published by Pleiades Publishing Ltd in Russian Journal of Organic Chemistry
- Vol. 59 (2) , 224-236
Synthesis and Affinity of Novel Triantennary Ligands for the Asialoglycoprotein Receptor
Novel triantennary N-acetylgalactosamine derivatives of tris(hydroxymethyl)aminomethane were synthesized and used to form complexes with the asialoglicoprotein receptor expressed on the hepatocellular surface. The equilibrium dissociation constants (KD) of the complexes of the asialoglicoprotein receptor with the synthesized compounds were measured by surface plasmon resonance spectroscopy. The KD values were in the subnanomolar range, being 6 orders of magnitude lower than the respective values for the complex of the receptor with the natural N-acetylgalactosamine ligand. The resulting data suggest that the synthesized ligands are promising agents for targeted delivery of various therapeutic agents in hepatocytes.
- 10 March 2021
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 32 (4) , 763-781
Discovery of Bivalent GalNAc-Conjugated Betulin as a Potent ASGPR-Directed Agent against Hepatocellular Carcinoma
Herein, we describe the design, synthesis, and biological evaluation of novel betulin and N-acetyl-d-galactosamine (GalNAc) glycoconjugates and suggest them as targeted agents against hepatocellular carcinoma. We prepared six conjugates derived via the C-3 and C-28 positions of betulin with one or two saccharide ligands. These molecules demonstrate high affinity to the asialoglycoprotein receptor (ASGPR) of hepatocytes assessed by in silico modeling and surface plasmon resonance tests. Cytotoxicity studies in vitro revealed a bivalent conjugate with moderate activity, selectivity of action, and cytostatic properties against hepatocellular carcinoma cells HepG2. An additional investigation confirmed the specific engagement with HepG2 cells by the enhanced generation of reactive oxygen species. Stability tests demonstrated its lability to acidic media and to intracellular enzymes. Therefore, the selected bivalent conjugate represents a new potential agent targeted against hepatocellular carcinoma. Further extensive studies of the cellular uptake in vitro and the real-time microdistribution in the murine liver in vivo for fluorescent dye-labeled analogue showed its selective internalization into hepatocytes due to the presence of GalNAc ligand in comparison with reference compounds. The betulin and GalNAc glycoconjugates can therefore be considered as a new strategy for developing therapeutic agents based on natural triterpenoids.
- 10 March 2021
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 32 (4) , 763-781
Discovery of Bivalent GalNAc-Conjugated Betulin as a Potent ASGPR-Directed Agent against Hepatocellular Carcinoma
Herein, we describe the design, synthesis, and biological evaluation of novel betulin and N-acetyl-d-galactosamine (GalNAc) glycoconjugates and suggest them as targeted agents against hepatocellular carcinoma. We prepared six conjugates derived via the C-3 and C-28 positions of betulin with one or two saccharide ligands. These molecules demonstrate high affinity to the asialoglycoprotein receptor (ASGPR) of hepatocytes assessed by in silico modeling and surface plasmon resonance tests. Cytotoxicity studies in vitro revealed a bivalent conjugate with moderate activity, selectivity of action, and cytostatic properties against hepatocellular carcinoma cells HepG2. An additional investigation confirmed the specific engagement with HepG2 cells by the enhanced generation of reactive oxygen species. Stability tests demonstrated its lability to acidic media and to intracellular enzymes. Therefore, the selected bivalent conjugate represents a new potential agent targeted against hepatocellular carcinoma. Further extensive studies of the cellular uptake in vitro and the real-time microdistribution in the murine liver in vivo for fluorescent dye-labeled analogue showed its selective internalization into hepatocytes due to the presence of GalNAc ligand in comparison with reference compounds. The betulin and GalNAc glycoconjugates can therefore be considered as a new strategy for developing therapeutic agents based on natural triterpenoids.
- 22 February 2021
- Published by Wiley in Macromolecular Bioscience
- Vol. 21 (4) , 2000371-e2000371
Mannosylated Cationic Copolymers for Gene Delivery to Macrophages
Macrophages are desirable targets for gene therapy of cancer and other diseases. Cationic diblock copolymers of polyethylene glycol (PEG) and poly‐L‐lysine (PLL) or poly{N‐[N‐(2‐aminoethyl)‐2‐aminoethyl]aspartamide} (pAsp(DET)) are synthesized and used to form polyplexes with a plasmid DNA (pDNA) that are decorated with mannose moieties, serving as the targeting ligands for the C type lectin receptors displayed at the surface of macrophages. The PEG‐b‐PLL copolymers are known for its cytotoxicity, so PEG‐b‐PLL‐based polyplexes are cross‐linked using reducible reagent dithiobis(succinimidyl propionate) (DSP). The cross‐linked polyplexes display low toxicity to both mouse embryonic fibroblasts NIH/3T3 cell line and mouse bone marrow‐derived macrophages (BMMΦ). In macrophages mannose‐decorated polyplexes demonstrate an ≈8 times higher transfection efficiency. The cross‐linking of the polyplexes decrease the toxicity, but the transfection enhancement is moderate. The PEG‐b‐pAsp(DET) copolymers display low toxicity with respect to the IC‐21 murine macrophage cell line and are used for the production of non‐cross‐linked pDNA‐contained polyplexes. The obtained mannose modified polyplexes exhibit ca. 500‐times greater transfection activity in IC‐21 macrophages compared to the mannose‐free polyplexes. This result greatly exceeds the targeting gene transfer effects previously described using mannose receptor targeted non‐viral gene delivery systems. These results suggest that Man‐PEG‐b‐pAsp(DET)/pDNA polyplex is a potential vector for immune cells‐based gene therapy.
- 22 February 2021
- Published by Wiley in Macromolecular Bioscience
- Vol. 21 (4) , 2000371-e2000371
Mannosylated Cationic Copolymers for Gene Delivery to Macrophages
Macrophages are desirable targets for gene therapy of cancer and other diseases. Cationic diblock copolymers of polyethylene glycol (PEG) and poly‐L‐lysine (PLL) or poly{N‐[N‐(2‐aminoethyl)‐2‐aminoethyl]aspartamide} (pAsp(DET)) are synthesized and used to form polyplexes with a plasmid DNA (pDNA) that are decorated with mannose moieties, serving as the targeting ligands for the C type lectin receptors displayed at the surface of macrophages. The PEG‐b‐PLL copolymers are known for its cytotoxicity, so PEG‐b‐PLL‐based polyplexes are cross‐linked using reducible reagent dithiobis(succinimidyl propionate) (DSP). The cross‐linked polyplexes display low toxicity to both mouse embryonic fibroblasts NIH/3T3 cell line and mouse bone marrow‐derived macrophages (BMMΦ). In macrophages mannose‐decorated polyplexes demonstrate an ≈8 times higher transfection efficiency. The cross‐linking of the polyplexes decrease the toxicity, but the transfection enhancement is moderate. The PEG‐b‐pAsp(DET) copolymers display low toxicity with respect to the IC‐21 murine macrophage cell line and are used for the production of non‐cross‐linked pDNA‐contained polyplexes. The obtained mannose modified polyplexes exhibit ca. 500‐times greater transfection activity in IC‐21 macrophages compared to the mannose‐free polyplexes. This result greatly exceeds the targeting gene transfer effects previously described using mannose receptor targeted non‐viral gene delivery systems. These results suggest that Man‐PEG‐b‐pAsp(DET)/pDNA polyplex is a potential vector for immune cells‐based gene therapy.